Lataa...
A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care
Noninvasive serum biomarkers (nonalcoholic fatty liver disease fibrosis score [NFS], fibrosis 4 score [FIB‐4], or enhanced liver fibrosis [ELF] test) are recommended as first‐line tools to determine the risk of advanced fibrosis in nonalcoholic fatty liver disease. We aimed to assess the utility of...
Tallennettuna:
| Julkaisussa: | Hepatol Commun |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078214/ https://ncbi.nlm.nih.gov/pubmed/30094401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1208 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|